Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer.
Chang Gon KimMinkyu JungHyo Song KimChoong-Kun LeeHei-Cheul JeungDong-Hoe KooWoo Kyun BaeDae Young ZangBum Jun KimHyunki KimUn-Jung YunJingmin CheSejung ParkTae Soo KimWoo Sun KwonJuin ParkSang Woo ChoChung-Mo NamHyun Cheol ChungSun Young RhaPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Trastuzumab combined with ramucirumab and paclitaxel showed appreciable efficacy with manageable safety profiles in patients with previously treated HER2-positive G/GEJ cancer.